secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001493152-22-032264
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma annual meeting results: directors elected, say-on-pay approved, auditor ratified
--------------------------------------------------------------------------------

- All 7 director nominees elected with ~92% of votes cast for each; broker non-votes ~62.5M shares.
- Advisory vote on executive compensation passed with 56.5M for, 6.9M against, 1.1M abstain.
- Ratification of EisnerAmper as auditor for FY 2022 approved with 126.1M for, 0.5M against, 0.5M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315222032264/0001493152-22-032264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315222032264/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-032264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer